An Act Expanding Health Insurance Coverage Of Specialized Formula For Individuals With Eosinophilic Gastrointestinal Disorders.
Impact
The passage of SB 200 is expected to have significant implications for state insurance regulations, particularly in how health insurance policies address dietary treatments for specific disorders. By mandating coverage for specialized formulas, the bill aims to ensure that necessary nutritional products are accessible to patients up to age 26 with eosinophilic gastrointestinal disorders, aligning with emerging medical standards and the needs of affected individuals. This increased coverage may result in improved health outcomes for these patients by facilitating better disease management through dietary interventions.
Summary
Senate Bill 200 aims to expand health insurance coverage for specialized formulae intended for individuals with eosinophilic gastrointestinal disorders. The bill specifies that individual health insurance policies must cover amino acid modified preparations and low protein modified food products for inherited metabolic diseases, as long as these products are prescribed and administered under medical supervision. This legislative change is set to take effect starting January 1, 2015, further enhancing the scope of coverage within state laws regarding nutritional treatments for specific medical conditions.
Sentiment
The initial sentiment surrounding SB 200 appears to be supportive, especially among healthcare providers and advocacy groups focused on patients with eosinophilic gastrointestinal disorders. The legislation is viewed as a positive step toward improving healthcare accessibility and ensuring that individuals with specific medical needs can receive appropriate nutritional support. However, some concerns have been raised regarding the implementation of the law and the potential impact on insurance premiums and policy administration.
Contention
Despite the overall support, there is contention regarding how this bill may affect insurance policy structures and premium pricing. Critics caution that expanding coverage requirements may lead to increased costs for insurers, which could ultimately be passed on to consumers unless appropriately managed. Additionally, the focus on specific conditions might raise questions about equity in healthcare coverage and whether similar coverage should be extended to other inherited metabolic diseases or health conditions.
An Act Concerning Insurance Market Conduct And Insurance Licensing, The Insurance Department's Technical Corrections And Other Revisions To The Insurance Statutes And Captive Insurance.
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans.(Formerly HF 479.)